Performance of CLB Core Laboratories NV | -17.1% in 12m
Compare CLB with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Core Laboratories NV with its related Sector/Index XLE
Performance Duell CLB vs XLE
| TimeFrame | CLB | XLE |
|---|---|---|
| 1 Day | 0.78% | 1.40% |
| 1 Week | 3.80% | 1.47% |
| 1 Month | 5.01% | -0.01% |
| 3 Months | 23.4% | 12.90% |
| 6 Months | -2.05% | 13.96% |
| 12 Months | -17.1% | 23.36% |
| YTD | 3.21% | 12.97% |
| Rel. Perf. 1m | 0.54 | |
| Rel. Perf. 3m | -0.76 | |
| Rel. Perf. 6m | -2.06 | |
| Rel. Perf. 12m | -3.75 |
Is Core Laboratories NV a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Core Laboratories NV is currently (May 2024)
neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 33.55 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLB as of May 2024 is 16.40. This means that CLB is currently overvalued and has a potential downside of -9.09% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLB as of May 2024 is 16.40. This means that CLB is currently overvalued and has a potential downside of -9.09% (Sold with Premium).
Is CLB a buy, sell or hold?
- Strong Buy: 0
- Buy: 1
- Hold: 6
- Sell: 1
- Strong Sell: 1
Values above 0%: CLB is performing better - Values below 0%: CLB is underperforming
Compare CLB with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.16% | -1.92% | -19.44% | -45.39% |
| US NASDAQ 100 | QQQ | 1.84% | -3.94% | -18.11% | -52.23% |
| US Dow Jones Industrial 30 | DIA | 2.41% | -0.45% | -16.83% | -38.99% |
| German DAX 40 | DBXD | 4.04% | -0.14% | -19.21% | -31.46% |
| UK FTSE 100 | ISFU | 2.26% | -4.54% | -18.29% | -31.73% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2.65% | 0.28% | -4.17% | -9.80% |
| Hongkong Hang Seng | HSI | 1.65% | -17.85% | -5.74% | -11.67% |
| Japan Nikkei 225 | EXX7 | 2.74% | 4.13% | -13.83% | -27.81% |
| India NIFTY 50 | INDA | 1.38% | 1.81% | -19.63% | -46.90% |
| Brasil Bovespa | EWZ | 3.89% | 1.72% | 1.71% | -29.79% |
CLB Core Laboratories NV vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.61% | 1.06% | -19.23% | -52.86% |
| Consumer Discretionary | XLY | 3.33% | -0.26% | -8.84% | -35.91% |
| Consumer Staples | XLP | 2.75% | -0.05% | -16.37% | -23.11% |
| Energy | XLE | 2.33% | 5.02% | -16.01% | -40.44% |
| Financial | XLF | 1.81% | -0.22% | -23.98% | -49.74% |
| Health Care | XLV | 1.81% | -0.29% | -16.36% | -30.33% |
| Industrial | XLI | 3.66% | 0.98% | -21.38% | -44.79% |
| Materials | XLB | 3.40% | 1.42% | -17.87% | -36.68% |
| Real Estate | XLRE | 1.56% | -3.02% | -10.85% | -27.94% |
| Technology | XLK | 1.23% | -5.01% | -16.71% | -52.68% |
| Utilities | XLU | 2.30% | -5.55% | -20.61% | -30.27% |
| Aerospace & Defense | XAR | 2.73% | -3.35% | -16.30% | -41.51% |
| Biotech | XBI | 2.35% | -5.07% | -26.14% | -23.91% |
| Homebuilder | XHB | 3.22% | -1.99% | -32.31% | -67.93% |
| Retail | XRT | 4.28% | -1.68% | -22.15% | -46.58% |
Does Core Laboratories NV outperform its market, is CLB a Sector Leader?
No, over the last 12 months Core Laboratories NV (CLB) made -17.08%, while its related Sector, the Energy Sector SPDR Fund (XLE) made 23.36%.
Over the last 3 months CLB made 23.39%, while XLE made 12.90%.
No, over the last 12 months Core Laboratories NV (CLB) made -17.08%, while its related Sector, the Energy Sector SPDR Fund (XLE) made 23.36%.
Over the last 3 months CLB made 23.39%, while XLE made 12.90%.
| Period | CLB | XLE | S&P 500 |
|---|---|---|---|
| 1 Month | 5.01% | -0.01% | 6.93% |
| 3 Months | 23.39% | 12.90% | 6.91% |
| 12 Months | -17.08% | 23.36% | 28.31% |